AI assistant
JOHNSON & JOHNSON — Director's Dealing 2024
Feb 15, 2024
29750_dirs_2024-02-14_dbeaeb56-154a-4589-a0a4-5a8cf57acd0e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2024-02-12
Reporting Person: Schmid Timothy (EVP, WW Chair, MedTech)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-12 | Common Stock | M | 4911.0000 | $0.0000 | Acquired | 14853.0000 | Direct |
| 2024-02-12 | Common Stock | M | 825.0000 | $0.0000 | Acquired | 15678.0000 | Direct |
| 2024-02-12 | Common Stock | F | 2887.0000 | $157.4000 | Disposed | 12791.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-12 | Performance Share Units | $ | M | 4911.0000 | Disposed | Common Stock (4911.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 700.0000 | Indirect |
| Common Stock | 46.0000 | Indirect |
Footnotes
F1: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024.
F2: Shares earned due to performance factor of 116.8% upon certification of performance results by the Board.
F3: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board.
F4: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2024).
F5: Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2024).